uniQure N.V. (QURE)

uniQure N.V. (QURE) is a healthcare company (biotechnology) based in the Netherlands. The share price is $20.81, down 4.89% on the day, which values the company at $1.46B. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$20.81−4.89% today
Market value
$1.46B
Funk Score
14/100
Against its own history
Well above its usual priceusual price $12.06
200-week average
$17.2521% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

uniQure N.V. in more detail

QURE trades at -7.4× next year's expected earnings, 72.4× sales. Measured against its own history, the price is 73% above what its usual multiples would imply ($12.06) — well above its usual price. It sits 21% above its 200-week average of $17.25.

Over the last five fiscal years uniQure N.V. has compounded revenue -15.6% a year. Its Funk Score is 14 out of 100 (financial strength 3.9, profitability 0.3, growth 1.3, value 0.0, each out of 10).

In its favour: More cash than debt. Worth checking: Altman Z in the distress zone; Share count keeps rising.

3 of the superinvestors tracked here hold QURE, including Lee Ainslie (0.4% of the portfolio), Anthony Bozza (0.1% of the portfolio), Richard Mashaal (0.0% of the portfolio).

Superinvestors holding QURE

3 of the investors tracked here report a position in their latest 13F filing.

uniQure N.V. (QURE): questions and answers

What is uniQure N.V.'s market cap?

uniQure N.V. is valued at $1.46B at a share price of $20.81.

Is QURE overvalued or undervalued?

Against its own history, QURE is well above its usual price: the price is 73% above the $12.06 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is QURE above its 200-week moving average?

Yes. QURE is 20.7% above its 200-week average of $17.25. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is uniQure N.V. growing?

Over the last five fiscal years uniQure N.V.'s revenue grew -15.6% a year; over ten years revenue grew 4.3% a year.

Does QURE pay a dividend?

uniQure N.V. does not currently pay a regular dividend.

Which famous investors own QURE?

In their latest quarterly filings, Lee Ainslie (0.4% of the portfolio), Anthony Bozza (0.1% of the portfolio), Richard Mashaal (0.0% of the portfolio) hold QURE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “uniQure N.V. (QURE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/QURE

Underlying data: Yahoo Finance; company filings with the SEC.